Eventide Gilead Class A (ETAGX)
| Fund Assets | 2.96B |
| Expense Ratio | 1.41% |
| Min. Investment | $1,000 |
| Turnover | 60.00% |
| Dividend (ttm) | 6.87 |
| Dividend Yield | 11.75% |
| Dividend Growth | 966.98% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 16, 2025 |
| Previous Close | 54.58 |
| YTD Return | -4.01% |
| 1-Year Return | 8.17% |
| 5-Year Return | -6.35% |
| 52-Week Low | 38.16 |
| 52-Week High | 59.99 |
| Beta (5Y) | n/a |
| Holdings | 70 |
| Inception Date | Oct 28, 2009 |
About ETAGX
The Eventide Gilead Fund Class A is an actively managed mutual fund focused on long-term capital appreciation through investment in a diversified portfolio of equity securities. Emphasizing a mid-cap growth strategy, the fund seeks opportunities across a broad range of industries and company sizes, often with historical concentrations in sectors such as healthcare, technology, and industrials. Managed since 2008 by Finny Kuruvilla, the fund is noted for its commitment to integrating ethical stewardship and impact considerations into its investment process, aiming to align value creation with positive outcomes for stakeholders. The portfolio may hold both domestic and international equities, including companies domiciled outside the United States. As a mid-cap growth fund, it targets firms projected to demonstrate above-average earnings and sales growth, potentially commanding higher valuations in the marketplace. The fund’s structure is designed to balance opportunities for growth with a level of volatility characteristic of its category, making it a significant participant in the active equity mutual fund segment oriented toward growth and ethical investing principles.
Performance
ETAGX had a total return of 8.17% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.76%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
32.98% of assets| Name | Symbol | Weight |
|---|---|---|
| Xometry, Inc. | XMTR | 5.63% |
| Guardant Health, Inc. | GH | 4.93% |
| Mirum Pharmaceuticals, Inc. | MIRM | 3.60% |
| Toast, Inc. | TOST | 2.95% |
| US BANK MMDA - USBGFS 9 | n/a | 2.83% |
| Trane Technologies plc | TT | 2.75% |
| iRhythm Holdings, Inc. | IRTC | 2.74% |
| United Rentals, Inc. | URI | 2.59% |
| GE Vernova Inc. | GEV | 2.52% |
| Verona Pharma PLC | VRNA | 2.43% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $6.8724 | Dec 17, 2025 |
| Dec 13, 2024 | $0.6441 | Dec 16, 2024 |
| Dec 15, 2022 | $2.2812 | Dec 16, 2022 |
| Dec 16, 2021 | $4.2652 | Dec 17, 2021 |
| Dec 17, 2020 | $0.5114 | Dec 17, 2020 |
| Dec 17, 2019 | $1.3176 | Dec 17, 2019 |